Skip to content Skip to footer
VIEWPOINTS_Lev Becker_2024

Onchilles Pharma at AACR 2024: Lev Becker in a Stimulating Conversation with PharmaShots

Shots: Recently, Onchilles Pharma unveiled findings from the late-stage preclinical data of its two candidates: N17350 and N17465 Today at PharmaShots, we had an engaging dialogue exchange with Lev Becker, Associate Professor, University of Chicago and Cofounder, Onchilles Pharma Lev highlights the unique novel mechanism that Onchilles Pharma leverages to treat a wide range of…

Read more